Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs

DR Tompa, A Immanuel, S Srikanth… - International journal of …, 2021 - Elsevier
The infectious microscopic viruses invade living cells to reproduce themselves, and causes
chronic infections such as HIV/AIDS, hepatitis B and C, flu, etc. in humans which may lead to …

Toll-like receptors in immunity and inflammatory diseases: Past, present, and future

K Vijay - International immunopharmacology, 2018 - Elsevier
The immune system is a very diverse system of the host that evolved during evolution to
cope with various pathogens present in the vicinity of environmental surroundings inhabited …

[HTML][HTML] Cancer vaccines as promising immuno-therapeutics: platforms and current progress

J Liu, M Fu, M Wang, D Wan, Y Wei, X Wei - Journal of Hematology & …, 2022 - Springer
Research on tumor immunotherapy has made tremendous progress in the past decades,
with numerous studies entering the clinical evaluation. The cancer vaccine is considered a …

Approved antiviral drugs over the past 50 years

E De Clercq, G Li - Clinical microbiology reviews, 2016 - Am Soc Microbiol
Since the first antiviral drug, idoxuridine, was approved in 1963, 90 antiviral drugs
categorized into 13 functional groups have been formally approved for the treatment of the …

2019 IUSTI‐Europe guideline for the management of anogenital warts

R Gilson, D Nugent, RN Werner… - Journal of the …, 2020 - Wiley Online Library
This guideline is an update of the 2011 European Guideline for the Management of
Anogenital Warts. It is intended to support best practice in the care of patients with …

TLR-based immune adjuvants

F Steinhagen, T Kinjo, C Bode, DM Klinman - Vaccine, 2011 - Elsevier
This work describes the nature and strength of the immune response induced by various Toll-
like receptor ligands and their ability to act as vaccine adjuvants. It reviews the various …

[HTML][HTML] Targeting innate immunity in cancer therapy

S Rameshbabu, BW Labadie, A Argulian, A Patnaik - Vaccines, 2021 - mdpi.com
The majority of current cancer immunotherapy strategies target and potentiate antitumor
adaptive immune responses. Unfortunately, the efficacy of these treatments has been limited …

Toll‐like receptors control autophagy

MA Delgado, RA Elmaoued, AS Davis, G Kyei… - The EMBO …, 2008 - embopress.org
Autophagy is a newly recognized innate defense mechanism, acting as a cell‐autonomous
system for elimination of intracellular pathogens. The signals and signalling pathways …

[HTML][HTML] Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota

B Shannon, TJ Yi, S Perusini, P Gajer, B Ma… - Mucosal …, 2017 - nature.com
Cervical human papillomavirus (HPV) infection may increase HIV risk. Since other genital
infections enhance HIV susceptibility by inducing inflammation, we assessed the impact of …

[图书][B] Human papillomaviruses

IARC Working Group on the Evaluation of … - 2007 - books.google.com
This ninetieth volume of the IARC Monographs on the Evaluation of Carcinogenic Risks to
Humansconsiders human papillomaviruses (HPVs) which were evaluated by a previous …